SHAREHOLDERS’ EQUITY (Details Narrative) - USD ($)		1 Months Ended				3 Months Ended		12 Months Ended
	Aug. 01, 2023	Aug. 31, 2023	Feb. 28, 2023	Jul. 31, 2022	Apr. 30, 2022	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Apr. 04, 2022	Apr. 30, 2020
Cash consideration	$ 16,792,037
Options to acquire shares					144,191
Weighted exercise price					$ 10.71
Warrants to purchase shares					4,424
Exercise price					$ 7.32
Payment of contingent consideration	893,000
Cash		$ 693,000
Cash consideration				$ 10,000,000.0
Number of shares				486,145
Earnout payment		$ 693,000
Number of shares issued, value							$ 1,033,761
Stock granted and issued								100,662
Restricted stock award, gross						$ 7,830,959
Share-based compensation						803,386	597,305
Unrecognized share-based compensation expense						$ 5,859,819
Unrecognized share-based compensation expense period for recognition						10 months 24 days
Selling, General and Administrative Expenses [Member]
Share-based compensation						$ 803,386
Research and Development Expense [Member]
Share-based compensation							$ 597,305
Cash Closing Consideration [Member]
Payments to acquire assets	$ 15,250,000
Stock issued during period shares issued for services	73,809
Purchase Agreement [Member]
Issuance of common stock in equity offering, shares				94,798
Payments to acquire assets				$ 7,600,000
Cash				$ 1,600,000
Issuance of common stock for purchase of assets				291,686
Common Stock [Member]
Issuance of common stock in equity offering, shares							26,143
Warrants to purchase shares					12,301
Exercise price					$ 12.05
Number of shares issued, value							$ 26
Common Stock [Member] | Sales Agreement [Member]
Issuance of common stock in equity offering, shares								26,143
Number of shares issued, value								$ 1,100,000
Net proceeds								$ 900,000
Precision Healing [Member]
Payment in cash					$ 600,000
Share price					$ 27.13					$ 27.13
Cantor Fitzgerald and Co [Member] | Sales Agreement [Member]
Percentage of commissions payable to sales agent			3.00%
Cantor Fitzgerald and Co [Member] | Sales Agreement [Member] | Maximum [Member]
Sale of stock, consideration received on transaction			$ 75,000,000
Accredited Investors [Member]
Accredited investors shares					165,738
Nonaccredited Investors [Member]
Share price									$ 30.75
Precision Healing Inc [Member]
Cash consideration					$ 125,966
Payment of contingent consideration					$ 10,000,000.0
Restated 2014 Omnibus Long Term Incentive Plan [Member]
Number of shares available for issuance						1,318,841
Restated 2014 Omnibus Long Term Incentive Plan [Member] | Directors Officers Employees [Member]
Issuance of common stock in equity offering, shares						681,159